Global Weight Loss D

Global Weight Loss Drugs, Supplements And Cosmetics Market

Report Code: UC 1699 Dec, 2018, by marketsandmarkets.com

Report Description

Individuals with high BMI have a greater risk of developing diseases such as cancer and diabetes. This holds true for both men and women; and those with BMI above 35 are at the highest risk. However, increasing awareness about obesity is encouraging consumers to seek medical assistance and consultation for weight reduction. The market for weight-loss drugs, cosmetics, and supplements is witnessing a significant growth as these do not involve strict diet or exercise regimens. Top pharmaceutical companies have thus increased R&D investments for anti-obesity drugs with minimal or no side effects.

Table of Contents

1. Market overview
   1.1. Market definitions
   1.2. Market evolution
   1.3. Market characteristics
   1.4. Market trends
   1.5. Relative risk percentage of chronic disease vs. BMI
   1.6. Utility vs. adversity analysis
   1.7. Stakeholder analysis
   1.8. Key findings

2. Weight Loss Drugs and Supplements Market
   2.1. Market drivers
   2.2. Market restraints
   2.3. Opportunity analysis
   2.4. Market forecast (2010 to 2015)
   2.5. Market structure and strategic analysis
        2.5.1. Prescription drugs
        2.5.2. Herbal diuretics and fat burners
        2.5.3. 5-HTP
        2.5.4. Spirulina supplements (algae tablets)
        2.5.5. Cimetidine
        2.5.6. Calcium/vitamins & carb blockers

3. Weight Loss Cosmetics Market
   3.1. Market drivers
   3.2. Market restraints
   3.3. Opportunity analysis
   3.4. Market forecast (2010 to 2015)
   3.5. Market structure and strategic analysis
        3.5.1. Slimming creams & serum
        3.5.2. Calorie off massage shapers
        3.5.3. Other cosmetics

4. Geographic Analysis
   4.1. North America
   4.2. Europe
   4.3. Asia and ROW

5. Competitive Landscape
   5.1. Key company analysis
   5.2. Recent developments
        5.2.1. Mergers and acquisitions
        5.2.2. New product launch
        5.2.3. Agreements and collaborations.
        5.2.4. * Market share

6. Strategic Market Assessment
   6.1. R&D efforts by major pharmaceutical companies
   6.2. Block buster drugs
   6.3. Winning imperatives
   6.4. Strategic recommendations
   6.5. Strategic conclusion

7. Company profiles
   7.1. Abbott Laboratories
   7.2. Alizyme Plc
   7.3. Amylin Pharmaceuticals, Inc
   7.4. AstraZeneca Plc
   7.5. F.Hoffmann-La Roche Ltd.
   7.6. GlaxoSmithKline Plc
   7.7. Sanofi-Aventis SA
   7.8. Takeda Pharmaceutical Company Limited
   7.9. VIVUS, Inc
   7.10. Others
*Subjected to the availability of information


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1699
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Global Weight Loss D
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved